6533b827fe1ef96bd128719b
RESEARCH PRODUCT
The Dual/Global Value of SARS-CoV-2 Genome Surveillance on Migrants Arriving to Europe via the Mediterranean Routes.
Claudia MarottaPaola StefanelliFabio TramutoUlrico AngeloniCarmelo MaidaAchille CernigliaroTeresa BaroneVitale FrancescoGiovanni RezzaWalter MazzuccoThe Sami-surv Collaborationsubject
Mediterranean climatePoint of entryCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)RefugeeInfectious and parasitic diseasesRC109-216Genome ViralSettore MED/42 - Igiene Generale E ApplicataGenomeMediterranean seaPandemicHumansSocioeconomicsLetters to the EditorSicilyTransients and MigrantsSARS-CoV-2COVID-19General MedicineGeographyCOVID-19 COVID-19 Vaccines Genome Viral Humans Molecular Diagnostic Techniques SARS-CoV-2Sicily Transients and MigrantsMolecular Diagnostic TechniquesPublic aspects of medicineRA1-1270description
Despite the pandemic, 34,154 migrants, refugees or asylum-seekers landed in Sicily (Italy) in 2020, representing the main point of entry by sea into Europe. The SARS-CoV-2 surveillance program among migrants arriving to Sicily via the Mediterranean Sea, made by the combination of clinical examination and molecular testing, has been integrated by full-genome sequencing strains using the NGS technology from the last week of February. To date, more than one hundred full-genome strains have been sequenced and 8 different lineages have been identified mostly belonging to the lineages B.1.1.7 and B.1.525. As global access to COVID-19 vaccines should be ensured, the need to provide more detailed information to inform policies and to drive the possible re-engineering of vaccines needed to deal with the challenge of new and future variants should be highlighted.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-07-30 | Annals of global health |